Testing Lumbrokinase for Long COVID, Lyme, and Chronic Fatigue
Part of Bones, joints & muscles, Brain & nervous system, Infections, Lungs & breathing clinical trials.
This trial tests a supplement called Lumbrokinase (derived from earthworms) to see if it helps reduce symptoms in people with Long COVID, post-treatment Lyme disease syndrome, or ME/CFS. It may benefit those whose daily life is significantly affected by these conditions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 or older and able to describe your symptoms before and after your infection.
- You must have a formal diagnosis from a doctor for one of these conditions: Long COVID, post-treatment Lyme disease syndrome, or ME/CFS.
- You should not be taking blood thinners or have a bleeding or clotting disorder.
- You cannot be pregnant or breastfeeding, and you must not have an allergy to earthworms.
- If you have an autoimmune condition (like MS or Hashimoto's), you may not be able to join.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether antiviral drugs (Truvada and Selzentry) can help people with long COVID. You may qualify if you have had long COVID symptoms for at least 6 months, including fatigue and post-exertional malaise.
This trial tests if gentle hands-on treatment (osteopathic manipulative therapy) can help relieve long-lasting COVID symptoms like fatigue, brain fog, and body pain.
This trial tests a new treatment for ME/CFS (chronic fatigue syndrome) that includes symptoms like dizziness when standing. It uses a smartphone app to track your progress and aims to see if the treatment can improve your daily life.
This trial tests a program to help people with ongoing fatigue, shortness of breath, or chest pain after COVID-19. It uses a personalized plan to improve your daily function and heart health.
This study looks at how cells make energy in people with Long COVID compared to people who fully recovered. It involves a blood draw, a small muscle sample, and a skin biopsy to understand why symptoms last.
This trial tests a medicine called Anktiva to see if it can help people with Long COVID. It's for adults who had a confirmed COVID-19 infection and now have lasting symptoms like fatigue, brain fog, or trouble breathing.
Hear when a new Long COVID trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.